Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Humana ( (HUM) ).
Humana on April 29, 2026 reported first-quarter 2026 GAAP EPS of $9.83 and adjusted EPS of $10.31, landing at the high end of its guidance range as its Insurance segment posted a slightly better-than-expected benefit ratio of 89.4 percent. The company affirmed full-year 2026 adjusted EPS guidance of at least $9.00 while trimming its GAAP EPS outlook to at least $8.36, maintained its forecast for roughly 25 percent individual Medicare Advantage membership growth over 2025, highlighted rapid expansion at CenterWell Senior Primary Care including the MaxHealth acquisition and new state-based contracts, and detailed an insurance leadership transition that will see Insurance Segment President George Renaudin retire on June 29, 2026 with Aaron Martin and John Barger stepping into expanded Medicare roles.
The most recent analyst rating on (HUM) stock is a Hold with a $173.00 price target. To see the full list of analyst forecasts on Humana stock, see the HUM Stock Forecast page.
Spark’s Take on HUM Stock
According to Spark, TipRanks’ AI Analyst, HUM is a Neutral.
The score is held back primarily by weakening earnings quality and cash generation (sharp 2025 OCF/FCF drop and margin compression), reinforced by conservative 2026 guidance tied to a sizable STARS headwind and near-term MA margin pressure. Technicals are supportive in the short term (price above 20/50 DMA and positive MACD) but appear somewhat stretched and still below longer-term averages, while valuation is middling with a ~26 P/E and a sub-1% yield.
To see Spark’s full report on HUM stock, click here.
More about Humana
Humana Inc., based in Louisville, Ky., is a health insurance and healthcare services company with a major focus on individual Medicare Advantage plans and related insurance products. Through its CenterWell-branded primary care and pharmacy operations and expanding state-based contracts, the company is building a broader national footprint in senior-focused and government-sponsored healthcare.
Average Trading Volume: 1,977,762
Technical Sentiment Signal: Sell
Current Market Cap: $26.85B
For a thorough assessment of HUM stock, go to TipRanks’ Stock Analysis page.